Cargando…
A Circulating Exosome RNA Signature Is a Potential Diagnostic Marker for Pancreatic Cancer, a Systematic Study
SIMPLE SUMMARY: Most patients with pancreatic cancer are diagnosed at an advanced stage due to the lack of tools with high sensitivity and specificity for early detection. Aberrant gene expression occurs in pancreatic cancer, which can be packaged into nanoparticles (also known as exosomes or nano-s...
Autores principales: | Wu, Yixing, Zeng, Hongmei, Yu, Qing, Huang, Huatian, Fervers, Beatrice, Chen, Zhe-Sheng, Lu, Lingeng |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8197236/ https://www.ncbi.nlm.nih.gov/pubmed/34073722 http://dx.doi.org/10.3390/cancers13112565 |
Ejemplares similares
-
A microRNA signature in circulating exosomes is superior to exosomal glypican-1 levels for diagnosing pancreatic cancer
por: Lai, Xianyin, et al.
Publicado: (2017) -
c-Met and PD-L1 on Circulating Exosomes as Diagnostic and Prognostic Markers for Pancreatic Cancer
por: Lux, Alexander, et al.
Publicado: (2019) -
Role of circulating exosomal biomarkers and their diagnostic accuracy in pancreatic cancer
por: Sha, Menazir, et al.
Publicado: (2022) -
Exosomal miRNA signatures of pancreatic lesions
por: Vicentini, Caterina, et al.
Publicado: (2020) -
A two-microRNA signature as a diagnostic and prognostic marker of pancreatic adenocarcinoma
por: Yu, Yang, et al.
Publicado: (2018)